Valuation (50%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 289.24 | 63.17 |
| PEG Ratio (TTM) | -3.58 | 5.09 |
| P/S Ratio (TTM) | 0.56 | 3.95 |
| P/B Ratio (TTM) | 1.48 | 8.18 |
| P/FCF Ratio (TTM) | -161.56 | 20.39 |
| Price to 5YR AVG Earnings Ratio | 26.12 | 34.98 |
| Price to 5YR AVG FCF Ratio | 18.20 | 27.87 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.30% | 7.23% |
| ROE (TTM) | 0.51% | 22.81% |
| Net Profit Margin (TTM) | 0.18% | 12.19% |
| ROIC 5YR AVG | 10.17% | 20.64% |
Growth (32%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -194.38% | -54.79% | -28.22% |
| Revenue | -1.20% | 7.28% | 2.38% |
| Net Income | -193.56% | -39.29% | -18.00% |
| Cash Flow | 16.17% | 1,020.74% | 609.48% |
Health (79%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.93 | 1.64 |
| Quick Ratio (TTM) | 1.83 | 1.60 |
| D/E Ratio (TTM) | 0.19 | 1.04 |
| Interest Coverage (TTM) | 1.02 | 152.97 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 4.36 | 5.56 |
| LTL to 5YR AVG FCF | 1.34 | 3.53 |
| Shares Outstanding Growth 5YR AVG | -0.68% | 3.16% |